FluMist’s approval for self- or caregiver-administration provides patients with increased accessibility to the seasonal ...

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

The Centers for Disease Control and Prevention encourages everyone more than six months old to get vaccinated against flu.

The CDC's Advisory Committee on Immunization Practices (ACIP) currently recommends routine vaccination against 15 potentially ...

According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

The WHO recommends manufacturers produce trivalent (three-strain) vaccines for use in the 2025 Southern Hemisphere influenza ...

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for ...

The service aims to improve vaccine accessibility for all citizens and residents, especially vulnerable groups such as ...

But there is a sweet spot to optimize your immunity.

Children born in 2020 to 2021 had lower coverage with nearly all childhood vaccines recommended by age 24 months than those ...

With thousands of press releases published each week, it can be difficult to keep up with everything on . To help healthcare ...